Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase iii study of the eortc lung cancer cooperative group
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (11) , 1759-1766
- https://doi.org/10.1016/s0959-8049(97)00174-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trialLung Cancer, 1994
- Immune Response Induced in Small-Cell Lung Cancer by Maintenance Therapy With InterferonJNCI Journal of the National Cancer Institute, 1993
- Natural interferon alfa as maintenance therapy for small cell lung cancerEuropean Journal Of Cancer, 1992
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- The interferons. Mechanisms of action and clinical applicationsJAMA, 1991
- Rationale for Recombinant Human Interferon-Gamma Adjuvant Immunotherapy for CancerJNCI Journal of the National Cancer Institute, 1988
- Small cell lung carcinoma. A phase II evaluation of r-interferon-γCancer, 1987
- Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferonCellular Immunology, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958